Common Stock, par value $0.001 per share
- Symbol
- PACB
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 5.02 · 8-K
Pacific Biosciences of California, Inc.
PACBNASDAQEQUITYCurrent
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
ITEM 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On July 8, 2026, Christopher M. Smith, a member of the board of directors (the “Board”) of Pacific Biosciences of California, Inc. (the “Company”), notified the Company of his resignation from the Board, effective immediately.…
Recent company filings
- 10-Q filingNov 5, 2026
- Results of Operations and Financial Condition · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsNov 4, 2026
- SCHEDULE 13G/A - filed by ARK Investment Management LLC regarding PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Aug 14, 2026
- S-8 filingAug 7, 2026
- 10-Q filingAug 6, 2026
Registered securities in this filing
Pacific Biosciences of California, Inc. · 8-K · Filed 2026-07-09
Disclosure sections
Item 5.02Item 5.02 - Departure/Election of Directors
ITEM 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
On July 8, 2026, Christopher M. Smith, a member of the board of directors (the “Board”) of Pacific Biosciences of California, Inc. (the “Company”), notified the Company of his resignation from the Board, effective immediately. The Company is not aware of any disagreement between Mr. Smith and the Company on any matter relating to the Company’s operations, policies or practices that resulted in Mr. Smith’s resignation.